Top Cited Articles
Acceptance Rate:
14%
Time to first decision with review:
57 days*
Impact Factor:
10.8
Impact Factor rank (JCR):
5/101
Citescore:
16.1
Total Altmetric mentions:
6,355
British Thoracic Society Guideline for pleural disease
Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis
British Thoracic Society Clinical Statement on chronic cough in adults
British Thoracic Society Clinical Statement on pleural procedures
British Thoracic Society Clinical Statement on pulmonary rehabilitation
Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial
BTS clinical statement on aspiration pneumonia
Core outcome set for pulmonary rehabilitation of patients with COPD: results of a modified Delphi survey
Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
A refresh of the top 10 research priorities in cystic fibrosis
Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial
Air pollution associated with incidence and progression trajectory of chronic lung diseases: a population-based cohort study
ABCA3-related interstitial lung disease beyond infancy
British Thoracic Society guideline for diagnosing and monitoring paediatric sleep-disordered breathing
Effect of obesity on airway and systemic inflammation in adults with asthma: a systematic review and meta-analysis
Prospective study of e-cigarette use and respiratory symptoms in adolescents and young adults
Appraising the causal role of smoking in idiopathic pulmonary fibrosis: a Mendelian randomization study
Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans
Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine